➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Dow
McKinsey
Merck
McKesson

Last Updated: May 6, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR SUPRANE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Suprane

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00762372 Japan Phase 2/3 Clinical Study With BLM-240 (Desflurane) Completed Baxter Healthcare Corporation Phase 2/Phase 3 2008-02-01 The purposes of this study are to evaluate the efficacy and safety of desflurane (BLM-240) as an anesthetic agent and to demonstrate the non-inferiority of desflurane to sevoflurane in term of awakening/recovery from anesthesia.
NCT00815269 Vasodilation Effect of Inhalational Anesthetics Completed Nanjing Medical University N/A 2008-12-01 Previous studies on animals suggest that inhalational anesthetics can reduce vascular tension in vitro resulting in vasodilation and decrease in blood pressure. This role for inhalational anesthetics has essential clinical implications such as the condition of sepsis or septic shock or other shock-associated states during which the blood vessel constricts strongly and leads to circulation dysfunction. The vasodilation property of these anesthetics including halothane, isoflurane, sevoflurane, desflurane and enflurane enables them to be better options than other general anesthetics in many clinical conditions needing the vasculature to be dilated. The investigators hypothesized that these inhalational anesthetics can evoke vasodilation measured with ultrasonography during general anesthesia in vivo as the in vitro studies displayed.
NCT01125982 Postoperative Fatigue and Nausea Related to Choice of Anaesthetic Regimens Completed Sykehuset Telemark Phase 4 2010-06-01 The purpose of this study is to establish validated outcome measures for Postoperative Fatigue and Postoperative nausea, and to compare clinical impact of postanaesthetic symptoms during first week after Propofol or Desflurane based anaesthesia.
NCT01171833 Ventilatory Effect on Speed of Anesthesia Under Various Inhaled Anesthetics Completed DongGuk University N/A 2010-06-01 Three groups of patients are going to have minor surgery under general anesthesia with inhaled anesthetics and different ventilatory setting (Tidal volume: 8, 10, 12 ml/kg, respiratory rate: 10/min each). Group A (Sevoflurane) will use sevoflurane, group B (Desflurane) will use desflurane, and group C (Isoflurane) will use isoflurane. It will be observed differences among the groups for ventilatory effects on speed of induction. Duration of this randomised controlled trial will be about 3 months. Estimated sample size will be 36 patients(12 in each group).
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Suprane

Condition Name

Condition Name for Suprane
Intervention Trials
Anesthesia 5
Obesity 2
Idiopathic Scoliosis 2
Pancreatic Neoplasms 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Suprane
Intervention Trials
Scoliosis 2
Unconsciousness 1
Pituitary Diseases 1
Respiratory Aspiration 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Suprane

Trials by Country

Trials by Country for Suprane
Location Trials
United States 5
Korea, Republic of 4
Japan 3
Germany 2
Turkey 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Suprane
Location Trials
Ohio 3
New York 1
California 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Suprane

Clinical Trial Phase

Clinical Trial Phase for Suprane
Clinical Trial Phase Trials
Phase 4 10
Phase 3 1
Phase 2/Phase 3 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Suprane
Clinical Trial Phase Trials
Completed 19
Recruiting 7
Not yet recruiting 3
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Suprane

Sponsor Name

Sponsor Name for Suprane
Sponsor Trials
Baxter Healthcare Corporation 4
Theodor Bilharz Research Institute 2
RWTH Aachen University 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Suprane
Sponsor Trials
Other 40
Industry 5
U.S. Fed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Moodys
Merck
Baxter
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.